Publications scientifiques 2008

1. Guilbaud M, Chadeuf G, Avolio F, François A, Moullier P, Recchia A, Salvetti A.Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration. J Virol. 2008 Mar;82(5):2590-3.

2. Moullier P., Snyder RO. International efforts for recombinant Adeno-Associated viral vector reference standards. Mol. Ther 2008 Jul ;16(7) :1185-8

3. Stieger K, Colle MA, Dubreil L, Mendes-Madeira A, Weber M, Le Meur G, Deschamps JY, Provost N, Nivard D, Cherel Y, Moullier P, Rolling F. Subretinal Delivery of Recombinant AAV Serotype 8 Vector in Dogs Results in Gene Transfer to Neurons in the Brain. Mol Ther. 2008 May ;16(5) :916-23.Epub 2008 Mar 11

4. Toromanoff A, Chérel Y, Guilbaud M., Penaud-Budloo M., Snyder RO, Haskins ME, Deschamps JY, Guigand L, Podevin G, Arruda VR, High KA, Stedman HH, Rolling F, Anegon I, Moullier P, Le Guiner C. Safety and efficacy of regional intravenous (RI) versus intramuscular (IM) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol Ther. 2008 Jul ;16(7) :1291-9.Epub 2008 May 6

5. Moreau A, Chiffoleau E, Beriou G, Deschamps JY, Heslan M, Ashton-Chess J, Rolling F, Josien R, Moullier P, Cuturi MC, Alliot-Licht B. Superiority of bon marrow-derived dendritic cells over monocyte-derived ones for the expansion of regulatory T cells in the macaque. Transplantation 2008 May 15 ;85(9) :1351-1356

6. Penaud-Budloo M, Le Guiner C, Nowrouzi A, Toromanoff A, Chérel Y, Chenuaud P, Schmidt M, Von Kalle C, Rolling F, Moullier P, Snyder RO. Adeno-associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle. J Virol. 2008 Aug ;82(16) :7875-85.Epub2008 Jun4).

7. Van Vliet KM, Blouin V, Brument N, Agbandje-McKenna M, Snyder RO. The role of the adeno-associated virus capsid in gene transfer. Methods Mol Biol, 2008 ;437 :51-91.

8. Barteau, B., Chevre, R., Letrou-Bonneval, E., Labas, R., Lambert, O. and Pitard, B. physicochemical parameter sof non-viral vectors that govern transfection efficiency. Curr Gene Ther. (2008) 8, 313-323

9. Pitard, B. Convergence of opposite sciences for the future development of non viral gene therapy. Curr Gene Ther (2008) 8, 295

10. Piron, J., Le Quang, K., Leoni, A.L., Desigaux, L., Amirault, J.C., Pitard, B., Escande, D. and Charpentier, F. Biological pacemaker engineered by non-viral gene transfer f complete atrioventricular block. Mol Ther (2008) 16, 1937-1943

11. Lamoureux, F., Picarda, G., Rousseau, J., Gourden G., Battaglia, S., Charrier, C., Pitard, B., Heymann, D. and Redini, F. Therapeutic efficacy of soluble receptor activator of NF-kB-Fc delivered by non viral gene transfer in a mouse model of osteolytic osteosarcoma. Cancer Research (2008) 7, 3389-3398

12. Letrou-Bonneval, E., Chevre, R., Lambert, O., Costet, P., Andre, C., Tellier, C. and Pitard, B. Galactosylated multimodular lipoplexes for specific gene transfer into primary hepatocytes. J. Gene Med. (2008) 10, 1198-1209

13. Richard, P., Payen, E., Chèvre, R., Zuber, J., Desigaux, L., Beuzard, Y. and Pitard, B. Therapy of anemia by plasmid EPO cDNA in kidney failure. Hum. Gene Ther. (2008) 19, 331-342